• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

Head of SFL Group presents on combined clinical trials under the MDR/IVDR

Shayesteh Fürst-Ladani, Head of SFL Group, will take part in the webinar organized by the Medtech & Pharma Platform on “DDC/IVDs Used in Clinical Trials: Principles and Sponsor Responsibilities Under MDR/IVDR” on 26 June 2023.

She will share insights into the current framework and initiatives for combination products together with experts from Roche and Bayer. The speakers will provide perspectives for clinical trials with combination products and companion diagnostics in the EU.

Registration for the webinar is open.

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top